Dopamine: PET Imaging and Parkinson Disease

Area of Science:

• Neuroscience
• Medical Imaging

Background:

• Parkinson disease (PD) is a neurodegenerative disorder affecting dopamine function.
• Accurate evaluation of dopaminergic systems is crucial for PD diagnosis and management.

Purpose of the Study:

• To review the current use of PET imaging in assessing dopamine function in Parkinson disease.
• To highlight major radioligands targeting dopaminergic systems.
• To showcase novel clinical applications of molecular imaging in PD.

Main Methods:

• Review of existing literature on PET imaging and dopaminergic radioligands in Parkinson disease.
• Discussion of clinical applications for diagnosis and symptom assessment.

Main Results:

• PET imaging offers valuable insights into dopamine function in PD.
• Various radioligands are available for targeting dopaminergic systems.
• Molecular imaging has emerging clinical roles in PD assessment.

Conclusions:

• PET imaging is a key tool for evaluating dopamine function in Parkinson disease.
• Radioligand development continues to advance molecular imaging in PD.
• Molecular imaging holds promise for improved diagnosis and comprehensive symptom evaluation in PD.